Medikamentöse Kontrolle kardiovaskulärer Risikofaktoren bei HIV-Patienten unter ART Therapie

Feinstein MJ, Nance RM, Drozd DR, Ning H, Delaney JA, Heckbert SR, Budoff MJ, Mathews WC, Kitahata MM, Saag MS, Eron JJ, Moore RD, Achenbach CJ, Lloyd-Jones DM, Crane HM (2017) Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: a study by the centers for AIDS research network of integrated clinical systems. JAMA Cardiol 2:155–162 Feinstein MJ, Nance RM, Delaney JAC, Heckbert SR, Budoff MJ, Drozd DR, Burkholder GA, Willig JH, Mugavero MJ, Mathews WC, Moore RD, Eron JJ, Napravnik S, Hunt PW, Geng E, Hsue P, Peter I, Lober WB, Crothers K, Grunfeld C, Saag MS, Kitahata MM, Lloyd-Jones DM, Crane HM (2019) Mortality following myocardial infarction among HIV-infected persons: the center for AIDS research network of integrated clinical systems (CNICS). BMC Med 17:149 Foy M, Sperati CJ, Lucas GM, Estrella MM (2014) Drug interactions and antiretroviral drug monitoring. Curr HIV/AIDS Rep 11:212–222 Fahme SA, Bloomfield GS, Peck R (2018) Hypertension in HIV-infected adults: novel pathophysiologic mechanisms. Hypertension 72:44–55